News and Updates

The FDA rejects Hengrui-Elevar's liver cancer drug for the third time, while GSK prepares for an FDA filing to expand Jemperli for rectal cancer treatment.

New stem cell therapy advances to clinical trials, offering hope for spinal cord injury recovery through regenerative nerve cell transplantation.

A new clinical trial is testing a breakthrough drug for weight management. Discover how this potential treatment could impact metabolic health and diabetes.

The US FDA issued a warning letter to a clinical investigator at an Alembic bioequivalence site over concerns regarding data integrity and study oversight.

New research suggests ibuprofen may safely reduce inflammation in drug-resistant tuberculosis patients, potentially improving outcomes for MDR-TB recovery.

Massive Bio and Sequence Me Now partner to revolutionize cancer clinical trial recruitment using AI to connect patients with precision medicine research.

Discover how simulation-guided clinical trials and digital twin technology are revolutionizing drug development and accelerating life-saving innovations.

The FDA is tightening oversight on global drug manufacturing with new registration updates and increased scrutiny of foreign plants. Read the details here.

Oncolytics Biotech reaches a major FDA milestone for its oncolytic virus, pelareorep, clearing the path for pivotal clinical trial advancement.

New research shows that simple digital check-ins significantly improve cancer treatment outcomes and patient quality of life. Learn how remote monitoring works.